🟢 OCGN Surges 5.8% as Company Presents at BIO Convention, Analysts Maintain 'Strong Buy'

OCGN is trading 5.8% up today at $1.36, extending recent upside momentum. - The company is presenting its modifier gene therapy platform at the BIO International Convention today, June 23, 2026, which may be driving investor interest. - Analysts have a "Strong Buy" consensus rating on the stock as of June 23, 2026, further supporting bullish sentiment.